Aimmune Therapeutics, Inc. EPS - Earnings per Share 2015-2020 | AIMT
Aimmune Therapeutics, Inc. eps - earnings per share from 2015 to 2020. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Aimmune Therapeutics, Inc. Annual EPS |
| 2019 |
$-3.97 |
| 2018 |
$-3.67 |
| 2017 |
$-2.61 |
| 2016 |
$-1.89 |
| 2015 |
$-1.88 |
| 2014 |
$-3.80 |
| 2013 |
$-1.65 |
| Aimmune Therapeutics, Inc. Quarterly EPS |
| 2020-06-30 |
$-1.06 |
| 2020-03-31 |
$-1.34 |
| 2019-12-31 |
$-1.06 |
| 2019-09-30 |
$-1.03 |
| 2019-06-30 |
$-1.01 |
| 2019-03-31 |
$-0.87 |
| 2018-12-31 |
$-0.95 |
| 2018-09-30 |
$-0.89 |
| 2018-06-30 |
$-0.91 |
| 2018-03-31 |
$-0.92 |
| 2017-12-31 |
$-0.81 |
| 2017-09-30 |
$-0.63 |
| 2017-06-30 |
$-0.65 |
| 2017-03-31 |
$-0.52 |
| 2016-12-31 |
$-0.56 |
| 2016-09-30 |
$-0.53 |
| 2016-06-30 |
$-0.43 |
| 2016-03-31 |
$-0.37 |
| 2015-12-31 |
$0.89 |
| 2015-09-30 |
$-0.36 |
| 2015-06-30 |
$-1.60 |
| 2015-03-31 |
$-0.81 |
| 2014-09-30 |
$-1.07 |
| 2014-06-30 |
$-0.94 |
